Overview:
The Cell Surface Markers Market is expanding as biomedical research increasingly relies on accurate identification and characterization of different cell populations. Cell surface markers are proteins, glycoproteins, and other molecules expressed on cell membranes that help researchers distinguish cell types, evaluate cellular states, and understand biological functions. The market...
The global acute myeloid leukemia (AML) treatment market is experiencing significant growth due to the rising incidence of blood cancers, increasing adoption of targeted therapies, growing investments in oncology research, and advancements in precision medicine. The global acute myeloid leukemia treatment market size was valued at USD 3.13 billion in 2025 and is projected to grow from...
The global Dasatinib Market was valued at USD 5.6 billion in 2025 and is projected to reach USD 7.6 billion by 2033, expanding at a CAGR of 4.3% from 2026 to 2033. The market is witnessing steady growth due to the increasing prevalence of hematologic cancers, particularly Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)....
The Hemato Oncology Testing Market research report highlights market research and industry analysis driven by in-depth business relevant news.
Precision Business Insights has published a report on the global Hemato Oncology Testing Market, estimating its value at USD 2.9 billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 14.8% over the forecast period...
The Leukemia Diagnostics Market research report highlights market research and industry analysis driven by in-depth business relevant news.
Precision Business Insights has published a report on the global Leukemia Diagnostics Market, estimating its value at USD 111.07 Billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 6.8% over the forecast period 2025-2031....
The latest study on the Molecular Oncology Diagnostics Market industry includes a detailed analysis of the future trends and demands for the forecast period, 2024 - 2033 . The report is furnished with the latest scenario and growth outlook of the market with regard to the impact of the pandemic.The report considers 2017-2018 as historical years, 2019 as the base year, and 2024- 2033 ...
MarkNtel Advisors recently published a detailed industry analysis of the Global Cancer Gene Panel and Profiling Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.
Global Cancer Gene Panel and Profiling Market, Share, and Trends Analysis Report – Industry Overview and Forecast to 2029...
[Hyderabad, 11th, June 2025] The Asia-Pacific companion diagnostics market has witnessed notable growth, reaching an estimated value of USD 1.67 billion in 2024. With rising healthcare investments and expanding oncology diagnostics infrastructure, the region now represents a significant share of the global market. Increased demand for personalized and precision medicine, along with a rise in...
[Portland, ME – May 9th, 2025] The global companion animal healthcare market is undergoing rapid transformation, projected to grow from USD 27.6 billion in 2023 to USD 50.1 billion by 2031, at a CAGR of 7.8% ClearView Market Insights, 2024). Growth is fueled by rising pet ownership, increased focus on preventive care, and advancements in animal diagnostics...
[Portland, ME – May 9th, 2025] The global companion animal healthcare market is undergoing rapid transformation, projected to grow from USD 27.6 billion in 2023 to USD 50.1 billion by 2031, at a CAGR of 7.8% ClearView Market Insights, 2024). Growth is fueled by rising pet ownership, increased focus on preventive care, and advancements in animal diagnostics...
According to the Market Statsville Group (MSG), the Global small molecule targeted cancer therapy Market was valued at USD 83,410 million in 2023 and is expected to grow from USD 91,333 million in 2024 to USD 1,88,780 million by 2033, by exhibiting a CAGR of 9.50 % during the forecast period (2024-2033)
Small-Molecule Targeted Cancer Therapy is a...
Bone Metastatic Diagnostics Market Overview:
Bone Metastatic Diagnostics Market, a common occurrence in advanced cancer patients, present a significant challenge for both diagnosis and treatment. The Bone Metastatic Diagnostics Market plays a crucial role in early detection and management of this condition, with evolving technologies and advancements in medical imaging techniques.
Market...
